Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06083207
Title A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Wollongong Private Hospital RECRUITING Wollongong New South Wales 2500 Australia Details
Peking Union Medical College Hospital NOT_YET_RECRUITING Beijing Beijing 100730 China Details
The first Affiliated Hospital of Guangxi Medical University NOT_YET_RECRUITING Nanning Guangxi 530021 China Details
Tongji Medical College of HUST Tongji Hospital NOT_YET_RECRUITING Wuhan Hubei 430030 China Details
Jiangsu Province Hospital NOT_YET_RECRUITING Nanjing Jiangsu 210029 China Details
The First Affiliated Hospital of Soochow University NOT_YET_RECRUITING Suzhou Jiangsu 215006 China Details
The Affiliated Hospital of Xuzhou Medical University NOT_YET_RECRUITING Xuzhou Jiangsu 221002 China Details
Jiangxi Cancer Hospital NOT_YET_RECRUITING Nanchang Jiangxi 330029 China Details
ZhongShan Hospital FuDan University NOT_YET_RECRUITING Shanghai Shanghai 201700 China Details
The First Affiliated Hospital of XI'AN Jiaotong University NOT_YET_RECRUITING Xian Shaxi 710061 China Details
Tianjin Medical University General Hospital NOT_YET_RECRUITING Tianjin Tianjin 300050 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field